Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP956828.RA0CoEFnasuqQeG5VbI2KWWtukKvY4YcSfIhcx09isSOc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP956828.RA0CoEFnasuqQeG5VbI2KWWtukKvY4YcSfIhcx09isSOc130_assertion type Assertion NP956828.RA0CoEFnasuqQeG5VbI2KWWtukKvY4YcSfIhcx09isSOc130_head.
- NP956828.RA0CoEFnasuqQeG5VbI2KWWtukKvY4YcSfIhcx09isSOc130_assertion description "[Target evaluation of parasitic DHS has recently been performed with CNI-1493, a novel selective pro-inflammatory cytokine inhibitor used in clinical phase II for the treatment of Crohn's disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP956828.RA0CoEFnasuqQeG5VbI2KWWtukKvY4YcSfIhcx09isSOc130_provenance.
- NP956828.RA0CoEFnasuqQeG5VbI2KWWtukKvY4YcSfIhcx09isSOc130_assertion evidence source_evidence_literature NP956828.RA0CoEFnasuqQeG5VbI2KWWtukKvY4YcSfIhcx09isSOc130_provenance.
- NP956828.RA0CoEFnasuqQeG5VbI2KWWtukKvY4YcSfIhcx09isSOc130_assertion SIO_000772 22694849 NP956828.RA0CoEFnasuqQeG5VbI2KWWtukKvY4YcSfIhcx09isSOc130_provenance.
- NP956828.RA0CoEFnasuqQeG5VbI2KWWtukKvY4YcSfIhcx09isSOc130_assertion wasDerivedFrom befree-20150227 NP956828.RA0CoEFnasuqQeG5VbI2KWWtukKvY4YcSfIhcx09isSOc130_provenance.
- NP956828.RA0CoEFnasuqQeG5VbI2KWWtukKvY4YcSfIhcx09isSOc130_assertion wasGeneratedBy ECO_0000203 NP956828.RA0CoEFnasuqQeG5VbI2KWWtukKvY4YcSfIhcx09isSOc130_provenance.